Seuraa
Ziad Bakouny
Ziad Bakouny
Memorial Sloan Kettering Cancer Center
Vahvistettu sähköpostiosoite verkkotunnuksessa mskcc.org
Nimike
Viittaukset
Viittaukset
Vuosi
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet 395 (10241), 1907-1918, 2020
19532020
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
DA Braun, Y Hou, Z Bakouny, M Ficial, M Sant’Angelo, J Forman, ...
Nature medicine 26 (6), 909-918, 2020
7362020
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
K Bi, MX He, Z Bakouny, A Kanodia, S Napolitano, J Wu, G Grimaldi, ...
Cancer Cell 39 (5), 649-661. e5, 2021
4192021
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
DA Braun, K Street, KP Burke, DL Cookmeyer, T Denize, CB Pedersen, ...
Cancer Cell 39 (5), 632-648. e8, 2021
3282021
Association of Clinical Factors and Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium
P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ...
Annals of Oncology, 2021
3252021
COVID-19 and cancer: current challenges and perspectives
Z Bakouny, JE Hawley, TK Choueiri, S Peters, BI Rini, JL Warner, ...
Cancer Cell 38 (5), 629-646, 2020
2922020
Beyond conventional immune-checkpoint inhibition—novel immunotherapies for renal cell carcinoma
DA Braun, Z Bakouny, L Hirsch, R Flippot, EM Van Allen, CJ Wu, ...
Nature Reviews Clinical Oncology, 1-16, 2021
2602021
Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic
Z Bakouny, M Paciotti, AL Schmidt, SR Lipsitz, TK Choueiri, QD Trinh
JAMA oncology 7 (3), 458-460, 2021
2562021
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes
PV Nuzzo, JE Berchuck, K Korthauer, S Spisak, AH Nassar, S Abou Alaiwi, ...
Nature Medicine 26 (7), 1041-1043, 2020
2482020
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ...
JAMA oncology 7 (8), 1167-1175, 2021
1892021
Transcriptional mediators of treatment resistance in lethal prostate cancer
MX He, MS Cuoco, J Crowdis, A Bosma-Moody, Z Zhang, K Bi, A Kanodia, ...
Nature Medicine 27 (3), 426-433, 2021
1522021
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study
DR Rivera, S Peters, OA Panagiotou, DP Shah, NM Kuderer, CY Hsu, ...
Cancer discovery 10 (10), 1514-1527, 2020
1482020
Results of a multicenter phase II study of atezolizumab and bevacizumab for patients with metastatic renal cell carcinoma with variant histology and/or sarcomatoid features
BA McGregor, RR McKay, DA Braun, L Werner, K Gray, A Flaifel, ...
Journal of Clinical Oncology 38 (1), 63-70, 2020
1402020
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
Z Bakouny, DA Braun, SA Shukla, W Pan, X Gao, Y Hou, A Flaifel, S Tang, ...
Nature communications 12 (1), 808, 2021
1232021
Evaluation of the safety and efficacy of immunotherapy rechallenge in patients with renal cell carcinoma
P Ravi, C Mantia, C Su, K Sorenson, D Elhag, N Rathi, Z Bakouny, ...
JAMA oncology 6 (10), 1606-1610, 2020
1152020
IL-8 and cancer prognosis on immunotherapy
Z Bakouny, TK Choueiri
Nature Medicine 26 (5), 650-651, 2020
1142020
COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer
AL Schmidt, C Labaki, CY Hsu, Z Bakouny, N Balanchivadze, SA Berg, ...
Annals of Oncology, 2021
1012021
Upfront cytoreductive nephrectomy for metastatic renal cell carcinoma treated with immune checkpoint inhibitors or targeted therapy: an observational study from the …
Z Bakouny, T El Zarif, S Dudani, JC Wells, CL Gan, F Donskov, J Shapiro, ...
European Urology 83 (2), 145-151, 2023
882023
Integrative clinical and molecular characterization of translocation renal cell carcinoma
Z Bakouny, A Sadagopan, P Ravi, NY Metaferia, J Li, S AbuHammad, ...
Cell Reports 38 (1), 110190, 2022
842022
Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
S Abou Alaiwi, W Xie, AH Nassar, S Dudani, D Martini, Z Bakouny, ...
Journal for Immunotherapy of Cancer 8 (1), e000144, 2020
842020
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20